allogeneic ex-vivo-treated peripheral blood mononuclear cells
Term · Oncology and biomedicine · MLC-T-ONC-009883
A preparation of allogeneic peripheral blood mononuclear cells (PBMCs) treated and induced ex vivo to undergo early apoptosis, with potential immunomodulating and antineoplastic activities. Upon administration of allogeneic ex-vivo-treated PBMCs, the early apoptotic cells are engulfed by macrophages and immature dendritic cells (DCs). This leads to immune modulation, which may result in immune-mediated tumor cell death.
| Identifier | MLC-T-ONC-009883 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | allogeneic ex-vivo-treated PBMCs |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009883",
"term": "allogeneic ex-vivo-treated peripheral blood mononuclear cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of allogeneic peripheral blood mononuclear cells (PBMCs) treated and induced ex vivo to undergo early apoptosis, with potential immunomodulating and antineoplastic activities. Upon administration of allogeneic ex-vivo-treated PBMCs, the early apoptotic cells are engulfed by macrophages and immature dendritic cells (DCs). This leads to immune modulation, which may result in immune-mediated tumor cell death.",
"synonyms": [
"allogeneic ex-vivo-treated PBMCs"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/allogeneic-ex-vivo-treated-peripheral-blood-mononuclear-cells/"
}
Record 769 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.